Research Studies
Study Title
Intermuscular Coherence as a Biomarker for ALS
Enrollment Status
Active - Not Recruiting
Principal Investigators
PI: Naoum Issa, MD, PhD (UChicago)
Site-PI: Nathan Carberry, MD
Study Type
Natural History
Goals
To determine whether intermuscular coherence (IMC) has value as a diagnostic and monitoring biomarker for ALS
Enrolling
ALS, Suspected ALS, Controls
Eligibility
Click to Expand
– Age 20-90
– Suspected or known to have ALS, or healthy controls
– Suspected or known to have ALS, or healthy controls
Study Involvement
Click to Expand
Demographic data collection and a 45-minute surface EMG session involving brief muscle-resistance tasks.
A subset of participants will be asked to return for follow-up assessment.
Contact
Primary Funding Source
NIH
Related Publications
Click to Expand
No items found
Related Presentations & Lectures
Click to Expand
No items found